Connect with us

Technology

Nagarro releases audited FY 2024 and unaudited Q1 2025 results, confirms existing guidance for 2025

Published

on

MUNICH, May 15, 2025 /PRNewswire/ — Nagarro, a global digital engineering leader, today announced its audited financial numbers for its full year ended December 31, 2024, and its unaudited financial numbers for the three months ended March 31, 2025. The Management Board and the Supervisory Board will propose to the Annual General Meeting a dividend of €1 per share.

Manas Human, Co-founder, said, “We are pleased to announce our robust results and confirm that we remain confident in our existing guidance for 2025. We have several growth and maturity initiatives now in motion, and we are excited about their potential to lift our trajectory in the months to come.”

2024 results

Revenue grew to €972.0 million in 2024, up from €912.1 million in 2023, a YoY growth of 6.6%. The constant currency growth in annual revenue was 7.2%. Gross profit grew to €295.8 million (as per the current method) and €253.9 million (as per the previous method) in 2024 from €235.7 million (as per the previous method) in 2023. As per the previous method, gross margin was 26.1% in 2024 compared to 25.8% in 2023. Adjusted EBITDA grew to €147.5 million in 2024 from €126.1 million in 2023. Adjusted EBITDA margin grew to 15.2% in 2024, up from 13.8% in 2023. EBITDA grew to €134.1 million in 2024 from €118.6 million in 2023. EBIT grew to €96.7 million in 2024 from €83.2 million in 2023. Net profit remained at €49.2 million in 2024, as in 2023. The number of clients doing more than €1 million in annual revenue with Nagarro rose from 181 in 2023 to 186 in 2024.

Operating cash flow grew to €86.5 million in 2024 from €79.7 million in 2023. Factoring utilization under the non-recourse factoring program was reduced by €3.5 million in 2024. Days of sales outstanding, calculated based on the quarterly revenue and including both contract assets and trade receivables, increased from 84 days on December 31, 2023, to 88 days on December 31, 2024.  

Nagarro’s cash balance at the end of 2024 was €192.6 million as against €110.1 million at the end of 2023. Nagarro’s loans and borrowings at the end of 2024 were €329.6 million as against €274.7 million at the end of 2023. The company reported 17,695 professionals as of December 31, 2024.

The Management Board and Supervisory Board will, for the first time, propose to the Annual General Meeting the distribution of a dividend of €1.00 per share. The proposed dividend marks an important milestone and underlines the company’s long-term value creation strategy.

As part of its commitment to strong corporate governance, the company will propose to the Annual General Meeting to expand the Supervisory Board. The newly proposed candidates – Martin Enderle, Hans-Paul Bürkner, and Jack Clemons – bring deep expertise in digital transformation, platform scaling, professional services, and finance and accounting. The company will also propose to reinstate Carl Georg Dürschmidt as a board member.

Q1 2025 results

Revenue grew to €246.9 million in 3M 2025, against €238.3 million in 3M 2024, a YoY growth of 3.6%. Gross profit was €75.5 million in 3M 2025, against €73.6 million in 3M 2024. Gross margin was 30.6% in 3M 2025, against 30.9% in 3M 2024. Adjusted EBITDA was €30.2 million in 3M 2025, against €39.2 million in 3M 2024. EBITDA was €33.0 million in 3M 2025, against €36.0 million in 3M 2024. EBIT was €24.1 million in 3M 2025, against €26.6 million in 3M 2024. Net profit was €11.2 million in 3M 2025, against €16.6 million in 3M 2024. The number of clients doing more than €1 million in annual revenue in the last 12 months with Nagarro rose from 181 on March 31, 2024, to 186 on March 31, 2025.

Operating cash flow grew to €29.8 million in 3M 2025, against €25.9 million in 3M 2024. Factoring utilization under the non-recourse factoring program was reduced by €6.7 million in 3M 2025 from December 31, 2024. Days of sales outstanding, calculated based on the quarterly revenue and including both contract assets and trade receivables, reduced to 81 days on March 31, 2025, from 88 days on December 31, 2024.

Nagarro’s cash balance at the end of March 31, 2025, was €162.2 million as against €192.6 million at the end of December 31, 2024. Nagarro’s loans and borrowings at the end of March 31, 2025, were €302.5 million as against €329.6 million at the end of 2024. The company reported 17,496 professionals as of March 31, 2025.

The summarized table for the twelve month period ended December 31, 2024, is as follows:

2024

2023

Growth

mEUR

mEUR

Revenue

972.0

912.1

6.6% YoY

7.2% YoY in constant currency

Gross profit (current method)

295.8

–

Gross profit (previous method)

253.9

235.7

7.7% YoY

Gross margin (current method)

30.4 %

–

Gross margin (previous method)

26.1 %

25.8 %

Adjusted EBITDA

147.5

126.1

16.9% YoY

Adjusted EBITDA margin

15.2 %

13.8 %

EBITDA

134.1

118.6

13.1% YoY

EBIT

96.7

83.2

16.3% YoY

Net profit

49.2

49.2

 

The summarized table for the three month period ended March 31, 2025, is as follows:

Q1

Q1

2025

2024

Growth

mEUR

mEUR

Revenue

246.9

238.3

3.6% YoY

2.4% YoY in constant currency

Gross profit

75.5

73.6

2.6% YoY

Gross margin

30.6 %

30.9 %

Adjusted EBITDA

30.2

39.2

Negative 22.8% YoY

Adjusted EBITDA margin

12.2 %

16.4 %

EBITDA

33.0

36.0

Negative 8.2% YoY

EBIT

24.1

26.6

Negative 9.5% YoY

Net profit

11.2

16.6

Negative 32.2% YoY

Nagarro SE will hold its analyst and investors meeting as a video call to discuss FY 2024 and Q1 2025 on May 15, 2025, at 1:00 pm CEST (4:00 am PT / 6:00 am CT / 7:00 am ET / 12:00 pm BST / 3:00 pm GST / 4:30 pm IST / 7:00 pm SGT / 8:00 pm JST).

 Nagarro SE will hold its retail investors call to discuss FY 2024 and Q1 2025 on May 15, 2025, at 2:30 pm CEST (5:30 am PT / 7:30 am CT / 8:30 am ET / 1:30 pm BST / 4:30 pm GST / 6:00 pm IST / 8:30 pm SGT / 9:30 pm JST).

To attend, please register in advance at https://www.nagarro.com/en/investor-relations/quarterly-statement-call-q1-2025 

About Nagarro

Nagarro, a global digital engineering leader, helps clients become fluidic, innovative, digital-first companies and thus win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its Fluidic Enterprise vision. Nagarro employs around 17,500 people in 39 countries. For more information, please visit www.nagarro.com.

(FRA: NA9) (ISIN DE000A3H2200, WKN A3H220)

For inquiries, please contact press@nagarro.com.

Logo: https://mma.prnewswire.com/media/844192/3850575/Nagarro_Logo.jpg 

 

View original content:https://www.prnewswire.com/news-releases/nagarro-releases-audited-fy-2024-and-unaudited-q1-2025-results-confirms-existing-guidance-for-2025-302456432.html

SOURCE Nagarro Software Private Limited

Continue Reading

Technology

STARMUS VIII — THE SEARCH FOR TRUTH

Published

on

By

From Nobel Prize Laureates and NASA Astronauts to Music Legends: STARMUS VIII Unites the World’s Greatest Minds in a Historic Celebration of Science, Music and Humanity

Tenerife & La Palma, Canary Islands, Spain | 17–22 October 2026

CANARY ISLANDS, Spain, Oct. 30, 2026 /PRNewswire/ — From the iconic sound of Sir Brian May’s legendary Red Special guitar and the extraordinary voices of Andrea Bocelli and Sarah Brightman to the groundbreaking discoveries of Nobel Prize-winning scientists, from NASA’s Artemis II astronauts preparing for humanity’s return to the Moon to historic tributes to Stephen Hawking and Jane Goodall, STARMUS VIII — The Search for Truth brought together an extraordinary constellation of scientific minds, legendary musicians, explorers and visionary thinkers for six unforgettable days in the Canary Islands.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/starmus-foundation/9430551-en-starmus-viii-the-search-for-truth-festival-2026

Held across Tenerife and La Palma from 17 to 22 October 2026, the eighth edition of STARMUS transformed the islands into a global stage for scientific discovery, artistic excellence and some of the most important conversations shaping humanity’s future.

Founded by astrophysicist Dr. Garik Israelian and legendary Queen guitarist and astrophysicist Sir Brian May, STARMUS once again demonstrated its unique ability to bridge science, music and society, bringing complex scientific ideas to audiences through extraordinary encounters, performances and shared experiences.

This year’s festival marked two defining milestones: the 10th anniversary of the Stephen Hawking Medal for Science Communication and the inauguration of the Jane Goodall Earth Medal, establishing a powerful connection between humanity’s ambition to explore the universe and its responsibility to protect the planet we call home.

Media Contacts:

US: Dan DuPont, dupont0708@gmail.com, +1 202 380 7558

UK/EU: Nicole Ettinger, nicole@ettingerpr.com, +44 7515 394107

Spain: Carlos Esteban, cesteban@llys.global, +34 699 55 2854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

View original content:https://www.prnewswire.com/news-releases/starmus-viii–the-search-for-truth-302924867.html

SOURCE Starmus Foundation

Continue Reading

Technology

Membrane Chromatography Market worth $0.63 billion by 2031 – Exclusive Report by MarketsandMarkets™

Published

on

By

DELRAY BEACH, Fla., Oct. 30, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Membrane Chromatography Market is projected to reach USD 0.63 billion by 2031 from USD 0.37 billion in 2026, at a CAGR of 11.3% during the forecast period.

Browse 417 market data Tables and 51 Figures spread through 343 Pages and in-depth TOC on ‘Membrane Chromatography Market – Global Forecast to 2031’

Membrane Chromatography Market Size & Forecast:

Market Size Available for Years: 2026–20312026 Market Size: USD 0.37 billion2031 Projected Market Size: USD 0.63 billionCAGR (2026–2031): 11.3%

Membrane Chromatography Market Trends & Insights:

By region, North America accounted for the largest share of ~37.4% of the market in 2025.By product, the capsules, cassettes, and cartridges segment is projected to register the highest CAGR of 12.0% in the membrane chromatography market during the forecast period.By technique, the ion exchange membrane chromatography segment accounted for the largest share of 58.1% of the membrane chromatography market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196

The membrane chromatography market is expected to grow steadily as pharmaceutical and biotechnology companies increase investments in biologics, biosimilars, vaccines, cell & gene therapies, and other advanced therapeutic modalities. Growing production of monoclonal antibodies, recombinant proteins, viral vectors, plasmid DNA, and mRNA is increasing demand for membrane chromatography products, including capsules, cassettes & cartridges, membrane discs & sheets, syringe filters, filter plates, spin columns, and other consumables & accessories. Rising adoption of single-use downstream processing, flow-through purification, affinity capture, and high-throughput polishing is improving process flexibility, throughput, and manufacturing efficiency. Advances in membrane materials, surface functionalization, and high-capacity affinity membranes are further enhancing selectivity, binding capacity, and purification performance. These factors are supporting adoption across pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and academic & research institutes.

The market is increasingly shifting toward high-throughput, single-use, and application-specific membrane chromatography solutions that can support complex biologics and advanced therapeutic modalities. Although conventional resin-based chromatography remains widely adopted, demand is increasing for advanced membrane formats, improved ligand chemistries, higher binding capacities, and intensified flow-through and bind-elute purification approaches that can reduce processing time and improve downstream productivity. Suppliers are expanding product portfolios and developing specialized membrane chemistries to support monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other biomolecules with challenging purification requirements. At the same time, manufacturers are addressing challenges related to membrane fouling, scalability, selectivity, pressure handling, and process consistency through advanced membrane materials and optimized purification workflows. The growing outsourcing of bioprocess development and manufacturing further supports specialized membrane chromatography providers that can deliver scalable, high-throughput purification solutions with shorter turnaround times and consistent performance.

The flow-through membrane chromatography segment is expected to register the highest growth rate in the membrane chromatography market during the forecast period.

The membrane chromatography market is segmented by operation mode into flow-through membrane chromatography and bind-elute membrane chromatography. During the forecast period, flow-through membrane chromatography is projected to grow faster, supported by rising demand for high-throughput impurity removal, polishing, and process intensification in biopharmaceutical manufacturing. Flow-through processing enables rapid processing, lower pressure drops, reduced buffer consumption, and easier integration with single-use and continuous downstream workflows. However, bind-elute membrane chromatography remains an important operating mode because it supports selective capture and purification of target biomolecules across biologics and advanced therapy manufacturing applications.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=151487196

North America accounted for the largest regional share of the global membrane chromatography market in 2025.

The membrane chromatography market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global market, driven by a well-established pharmaceutical and biotechnology industry, strong biopharmaceutical R&D activity, significant biologics manufacturing capacity, and widespread adoption of advanced downstream purification technologies. The region also benefits from major membrane chromatography product providers, pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and research institutions. Continued development and commercialization of monoclonal antibodies, vaccines, viral vectors, and other advanced therapeutics, along with increasing adoption of single-use and high-throughput purification solutions, further support the region’s leading market position.

Key Players

Leading players in the Membrane Chromatography companies include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), i3 Membrane GmbH (Germany), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and MICROSOLV (US), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=151487196

Investment & Funding Context

The membrane chromatography market is seeing increased investment as companies and research organizations focus on developing high-capacity membranes, scaling up manufacturing, advancing continuous downstream processing, and commercializing single-use purification technologies.

In June 2026, MembraneWorks, Inc. received USD 350,000 through the North Carolina Biotechnology Center’s Small Business Research Loan program to develop high-capacity nonwoven membrane chromatography devices for biopharmaceutical purification. The funding supports further development and commercialization of membrane-based downstream purification technologies.

In June 2025, a North Carolina State University research team received funding under the Gates Foundation-supported Grand Challenges initiative to develop a low-cost, all-membrane chromatography process to purify the antimalarial monoclonal antibody MAM01. The project focuses on single-use membranes, membrane-coupled ligands, scalable device configurations, integration into single-use cassettes, and development of an affordable, scalable biomanufacturing platform. These developments indicate continued funding toward membrane chromatography commercialization, high-capacity membrane devices, single-use purification, process intensification, and scalable biologics manufacturing.

Revenue Shift Context

The membrane chromatography market is gradually shifting from conventional resin-based chromatography and standalone filtration toward a broader mix of single-use membrane adsorbers, high-capacity affinity membranes, flow-through purification solutions, and application-specific consumables. Traditional products such as capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, and membrane discs & sheets remain important revenue pools; however, customers increasingly seek integrated downstream solutions supporting monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other advanced therapeutic modalities.

Rising demand for single-use and high-throughput purification is further increasing consumption of specialized membrane formats and functionalized chemistries. At the same time, growing outsourcing by pharmaceutical & biopharmaceutical companies to CROs & CDMOs is expanding revenue opportunities for scalable purification platforms and related consumables. Over the forecast period, revenue growth is therefore expected to increasingly favor recurring membrane consumables, affinity membrane chromatography, advanced membrane materials, and integrated flow-through downstream processing workflows.

Mergers & Acquisitions

Mergers & acquisitions in the membrane chromatography market are increasingly focused on expanding downstream purification capabilities, strengthening membrane and filtration portfolios, and improving access to biopharmaceutical manufacturing customers. Buyers are prioritizing technologies that complement single-use processing, membrane-based separations, and integrated upstream-to-downstream workflows.

MEMBRANE CHROMATOGRAPHY MARKET: MERGERS & ACQUISITIONS, JANUARY 2025–SEPTEMBER 2026

Month & Year

Deal Type

Company
1

Company
2

Description

September 2025

Acquisition

Thermo Fisher Scientific Inc. (US)

Solventum Corporation – Purification & Filtration Business (US)

Thermo Fisher Scientific completed the acquisition of Solventum’s Purification & Filtration business for approximately USD 4.0 billion. The acquired business includes bioprocessing filtration and membrane technologies supporting upstream and downstream biopharmaceutical manufacturing. The portfolio includes Polisher ST Membrane Adsorber, a single-use anion exchange membrane chromatography solution for flow-through polishing and removal of host cell proteins, DNA, viruses, and other impurities. The acquisition strengthens Thermo Fisher’s membrane-based purification and broader downstream bioprocessing capabilities.

Company Revenue Share Details

The top four players collectively account for approximately 73–77% of the global membrane chromatography market, indicating a consolidated landscape. The market comprises a mix of diversified life science companies and specialized membrane chromatography product manufacturers. Leading players include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), i3 Membrane GmbH (Germany), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), MICROSOLV (US), among others. Their portfolio spans membrane adsorbers, capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, membrane discs & sheets, and other consumables, along with ion exchange, affinity, and hydrophobic interaction membrane chromatography solutions. The coexistence of large, diversified companies and specialized membrane technology providers creates significant scope for continued competition and consolidation, particularly as companies expand single-use purification portfolios, high-capacity affinity membrane technologies, advanced membrane materials, and geographic reach.

Browse Adjacent Market: Biotechnology Market Research Reports &Consulting

See More Latest Biotechnology Reports:

Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) – Global Forecast to 2031

Chromatography Columns Market by Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) – Global Forecast to 2031

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/membrane-chromatography-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/membrane-chromatography.asp

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/membrane-chromatography-market-worth-0-63-billion-by-2031—exclusive-report-by-marketsandmarkets-302924841.html

Continue Reading

Technology

In HelloNation, Assisted Living Experts Rusty and Kelly Ackerman Explain Why Amenities Matter More Than Families Expect

Published

on

By

The article examines how amenities shape daily routines, independence, and social connection in senior living communities.

TRAVERSE CITY, Mich., Oct. 30, 2026 /PRNewswire/ — Why do senior living amenities have a greater impact on daily life than many families initially expect? HelloNation has released an article that explains how these features influence comfort, independence, and social connection in meaningful ways.

The article features insights from Assisted Living Experts Rusty and Kelly Ackerman of French Manor Assisted Living in Traverse City, Michigan, and highlights how senior living amenities play a central role in shaping everyday experiences within a community.

The HelloNation article explains that while families often focus on apartments and care services, senior living amenities are deeply connected to how residents spend their time. These amenities are not simply added features but part of the daily routine that supports both independence and engagement.

Dining options are one of the most impactful elements discussed. The article notes that meals are a daily experience that influence routine, health, and social connection. Asking about variety and flexibility helps families understand how dining options support both independence and comfort over time.

The article also explains that flexible dining options allow residents to make choices about when and what they eat. This ability to choose supports independence and reinforces a sense of control, which is especially important during transitions into a new living environment.

Activity spaces are another essential component of senior living amenities. The article describes how these spaces support hobbies, group events, and informal gatherings. Well-used activity spaces encourage residents to remain engaged and provide natural opportunities for social connection throughout the day.

In addition, activity spaces help foster spontaneous interaction. Residents may gather for conversation or shared interests, which strengthens community bonds. The article emphasizes that accessible and active spaces contribute directly to both engagement and independence.

Outdoor areas also play a significant role in daily life. The article explains that access to outdoor areas allows residents to enjoy fresh air, walk safely, and experience a change of environment. These outdoor areas help create a balanced routine and support emotional well-being.

The article further notes that time spent outdoors can improve mood and reduce stress. When outdoor areas are designed with safety and accessibility in mind, they support both independence and overall comfort.

Wellness programs are another key aspect of senior living amenities. The article describes how these programs provide structure through fitness and health-focused activities. Consistent wellness programs help residents maintain strength, confidence, and long-term well-being.

Wellness programs also encourage social connection by bringing residents together in shared activities. Participation in these programs helps build relationships while supporting physical health, reinforcing a sense of purpose within the community.

The article highlights that social connection is often shaped by how effectively senior living amenities are used. Dining options, activity spaces, outdoor areas, and wellness programs all create opportunities for interaction that help residents feel connected rather than isolated.

Senior living amenities also support independence in practical ways. Easy access to these features allows residents to make choices throughout the day, reinforcing confidence and autonomy over time.

Overall, the HelloNation article emphasizes that senior living amenities play a direct role in shaping comfort, independence, and social connection. Families are encouraged to look beyond appearance and ask how these amenities function on a daily basis to better understand the full living experience.

For families evaluating options, the article provides a clear perspective on how senior living amenities contribute to quality of life in ways that may not be immediately visible during a tour.

Why Amenities Matter More Than Families Expect features insights from Rusty and Kelly Ackerman, Assisted Living Experts of Traverse City, Michigan, in HelloNation.

About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-assisted-living-experts-rusty-and-kelly-ackerman-explain-why-amenities-matter-more-than-families-expect-302925027.html

SOURCE HelloNation

Continue Reading

Trending